Biohaven Ltd
BHVN
Market Cap$1.51B
Close$
$0.69
95.4% downside
Current Fair Value
95.4% downsideOvervalued by 95.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.51 Billion |
|---|---|
| Enterprise Value | $1.46 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-9.28 |
| Beta | 4.18 |
| Outstanding Shares | 101,943,396 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.7 |
|---|---|
| PEG | -7.23 |
| Price to Sales | - |
| Price to Book Ratio | 7.41 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.59 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Biohaven Pharmaceutical Holding Company Ltd
CEO: Vlad Coric